426 related articles for article (PubMed ID: 19197823)
1. Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo.
Enck P; Zimmermann K; Menke G; Klosterhalfen S
Z Gastroenterol; 2009 Feb; 47(2):209-14. PubMed ID: 19197823
[TBL] [Abstract][Full Text] [Related]
2. A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome--a randomized controlled trial with primary care physicians.
Enck P; Zimmermann K; Menke G; Müller-Lissner S; Martens U; Klosterhalfen S
Neurogastroenterol Motil; 2008 Oct; 20(10):1103-9. PubMed ID: 18565142
[TBL] [Abstract][Full Text] [Related]
3. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
4. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
Bittner AC; Croffut RM; Stranahan MC
Clin Ther; 2005 Jun; 27(6):755-61. PubMed ID: 16117982
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.
Kim HJ; Vazquez Roque MI; Camilleri M; Stephens D; Burton DD; Baxter K; Thomforde G; Zinsmeister AR
Neurogastroenterol Motil; 2005 Oct; 17(5):687-96. PubMed ID: 16185307
[TBL] [Abstract][Full Text] [Related]
6. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of probiotics in the treatment of irritable bowel syndrome.
Wilhelm SM; Brubaker CM; Varcak EA; Kale-Pradhan PB
Pharmacotherapy; 2008 Apr; 28(4):496-505. PubMed ID: 18363533
[TBL] [Abstract][Full Text] [Related]
8. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS.
Hun L
Postgrad Med; 2009 Mar; 121(2):119-24. PubMed ID: 19332970
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
Rahimi R; Nikfar S; Abdollahi M
Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of irritable bowel syndrome with Escherichia coli strain Nissle 1917 (EcN): a retrospective survey].
Plassmann D; Schulte-Witte H
Med Klin (Munich); 2007 Nov; 102(11):888-92. PubMed ID: 17992479
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.
Chang FY; Lu CL; Chen CY; Luo JC
J Gastroenterol Hepatol; 2007 Dec; 22(12):2266-72. PubMed ID: 17559369
[TBL] [Abstract][Full Text] [Related]
12. Treatment of irritable bowel syndrome. A case control experience.
Astegiano M; Pellicano R; Terzi E; Simondi D; Rizzetto M
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
[TBL] [Abstract][Full Text] [Related]
13. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
Leung WK; Wu JC; Liang SM; Chan LS; Chan FK; Xie H; Fung SS; Hui AJ; Wong VW; Che CT; Sung JJ
Am J Gastroenterol; 2006 Jul; 101(7):1574-80. PubMed ID: 16863563
[TBL] [Abstract][Full Text] [Related]
14. Clinical studies on alleviating the symptoms of irritable bowel syndrome.
Kajander K; Korpela R
Asia Pac J Clin Nutr; 2006; 15(4):576-80. PubMed ID: 17077079
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study.
Andriulli A; Neri M; Loguercio C; Terreni N; Merla A; Cardarella MP; Federico A; Chilovi F; Milandri GL; De Bona M; Cavenati S; Gullini S; Abbiati R; Garbagna N; Cerutti R; Grossi E
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S218-23. PubMed ID: 18685503
[TBL] [Abstract][Full Text] [Related]
16. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
Kajander K; Hatakka K; Poussa T; Färkkilä M; Korpela R
Aliment Pharmacol Ther; 2005 Sep; 22(5):387-94. PubMed ID: 16128676
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
Kajander K; Myllyluoma E; Rajilić-Stojanović M; Kyrönpalo S; Rasmussen M; Järvenpää S; Zoetendal EG; de Vos WM; Vapaatalo H; Korpela R
Aliment Pharmacol Ther; 2008 Jan; 27(1):48-57. PubMed ID: 17919270
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome.
Boyce PM; Talley NJ; Balaam B; Koloski NA; Truman G
Am J Gastroenterol; 2003 Oct; 98(10):2209-18. PubMed ID: 14572570
[TBL] [Abstract][Full Text] [Related]
19. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
Dolin BJ
Methods Find Exp Clin Pharmacol; 2009 Dec; 31(10):655-9. PubMed ID: 20140275
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome.
Mangel AW; Bornstein JD; Hamm LR; Buda J; Wang J; Irish W; Urso D
Aliment Pharmacol Ther; 2008 Jul; 28(2):239-49. PubMed ID: 18466359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
